Data / Form D filings / MAPS Public Benefit Corp
MAPS Public Benefit Corp: Form D filing
MAPS Public Benefit Corp, a pharmaceuticals company in San Jose, CA, filed a Form D with the SEC in 2023. The latest, on September 29, 2023, reports $215.1 million sold of an offering with no set size to 62 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3141 STEVENS CREEK BLVD, #40547, San Jose, CA, 95117
- Phone
- (831) 429-6362
- Industry
- Pharmaceuticals
- Entity type
- Other (Public Benefit Corporation)
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1995302
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2023 | New notice | Indefinite | $215,099,807 | 62 | Sep 15, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffery George | Director | |
| Amy Emerson | Executive Officer, Director | |
| Andrew Septimus | Executive Officer | |
| Berra Yazar-Klosinski | Executive Officer | |
| Michael Mullette | Executive Officer | |
| Blair Clark-Schoeb | Executive Officer | |
| Dawn McCollough | Director | |
| Arman Nadershahi | Executive Officer | |
| Suprotik Basu | Director | |
| Jason Pyle | Director | |
| Gisselle Acevedo | Director | |
| Daniel Grossman | Director | |
| Richard Doblin | Director | |
| James Acer | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 25, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MAPS Public Benefit Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.